• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Antiretroviral Drugs

ViiV HQ
Pharma

ViiV girds data package for Cabenuva in competitive HIV market

Cabenuva hit superior viral suppression versus oral antiretrovirals in adults and adolescents with HIV-1 with viremia in the phase 3b Crown study.
Fraiser Kansteiner Oct 6, 2026 10:59am
handshake deal shake hand arrows ok yes

Merck prepares expanded access to monthly PrEP pill early

Jul 24, 2026 10:40am
HIV

Gilead, Merck phase 3 data back first weekly HIV pill

Jul 21, 2026 10:00am
Gilead

Gilead's bictegravir, lenacapavir tablet meets mark in phase 3

Nov 13, 2025 9:55am
Gilead

Gilead's PrEP shows early promise in once-yearly dosing

Mar 11, 2025 2:30pm
head to head against clash football helmets fight combat

GSK's Dovato matches Gilead's Biktarvy with less weight gain

Jul 23, 2024 4:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings